OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Outlook Therapeutics, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026
$0.49+0.00 (+0.98%)
Close on Oct 19, 2026
- Market cap
- $67.41M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Outlook Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 25, 2026 | Sep 30, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 23, 2026 | Aug 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 18, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2026 | Jul 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2026 | Jul 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 16, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2026 | Jun 16, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 16, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 1, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | May 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 28, 2026 | May 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 26, 2026 | May 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 22, 2026 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2026 | Apr 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2026 | Mar 11, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 10, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2025 | Jan 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2025 | Sep 5, 2025 | SEC EDGAR |